Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis

Nat Commun. 2019 Jan 14;10(1):181. doi: 10.1038/s41467-018-08097-7.

Abstract

Whether sensory nerve can sense bone density or metabolic activity to control bone homeostasis is unknown. Here we found prostaglandin E2 (PGE2) secreted by osteoblastic cells activates PGE2 receptor 4 (EP4) in sensory nerves to regulate bone formation by inhibiting sympathetic activity through the central nervous system. PGE2 secreted by osteoblasts increases when bone density decreases as demonstrated in osteoporotic animal models. Ablation of sensory nerves erodes the skeletal integrity. Specifically, knockout of the EP4 gene in the sensory nerves or cyclooxygenase-2 (COX2) in the osteoblastic cells significantly reduces bone volume in adult mice. Sympathetic tone is increased in sensory denervation models, and propranolol, a β2-adrenergic antagonist, rescues bone loss. Furthermore, injection of SW033291, a small molecule to increase PGE2 level locally, significantly boostes bone formation, whereas the effect is obstructed in EP4 knockout mice. Thus, we show that PGE2 mediates sensory nerve to control bone homeostasis and promote regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Fibers / drug effects
  • Adrenergic Fibers / metabolism
  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Bone Density / drug effects
  • Bone Regeneration / drug effects
  • Bone and Bones / cytology
  • Bone and Bones / innervation
  • Bone and Bones / metabolism*
  • Bone and Bones / pathology
  • Cells, Cultured
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Dinoprostone / metabolism*
  • Disease Models, Animal
  • Feedback, Physiological
  • Female
  • Humans
  • Hydroxyprostaglandin Dehydrogenases / antagonists & inhibitors
  • Hydroxyprostaglandin Dehydrogenases / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • Osteoporosis / etiology
  • Osteoporosis / pathology*
  • Propranolol / pharmacology
  • Pyridines / pharmacology
  • Receptors, Prostaglandin E, EP4 Subtype / genetics
  • Receptors, Prostaglandin E, EP4 Subtype / metabolism*
  • Sensory Receptor Cells / drug effects
  • Sensory Receptor Cells / metabolism*
  • Thiophenes / pharmacology

Substances

  • Adrenergic beta-Antagonists
  • Ptger4 protein, mouse
  • Pyridines
  • Receptors, Prostaglandin E, EP4 Subtype
  • SW033291
  • Thiophenes
  • Propranolol
  • Hydroxyprostaglandin Dehydrogenases
  • 15-hydroxyprostaglandin dehydrogenase
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Dinoprostone